These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 35162978)

  • 1. Beneficial and Sexually Dimorphic Response to Combined HDAC Inhibitor Valproate and AMPK/SIRT1 Pathway Activator Resveratrol in the Treatment of ALS Mice.
    Bankole O; Scambi I; Parrella E; Muccilli M; Bonafede R; Turano E; Pizzi M; Mariotti R
    Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35162978
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synergistic association of resveratrol and histone deacetylase inhibitors as treatment in amyotrophic lateral sclerosis.
    Parrella E; Porrini V; Scambi I; Gennari MM; Gussago C; Bankole O; Benarese M; Mariotti R; Pizzi M
    Front Pharmacol; 2022; 13():1017364. PubMed ID: 36339574
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acetylation state of RelA modulated by epigenetic drugs prolongs survival and induces a neuroprotective effect on ALS murine model.
    Schiaffino L; Bonafede R; Scambi I; Parrella E; Pizzi M; Mariotti R
    Sci Rep; 2018 Aug; 8(1):12875. PubMed ID: 30150770
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synergistic Association of Valproate and Resveratrol Reduces Brain Injury in Ischemic Stroke.
    Faggi L; Pignataro G; Parrella E; Porrini V; Vinciguerra A; Cepparulo P; Cuomo O; Lanzillotta A; Mota M; Benarese M; Tonin P; Annunziato L; Spano P; Pizzi M
    Int J Mol Sci; 2018 Jan; 19(1):. PubMed ID: 29316653
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeted acetylation of NF-kappaB/RelA and histones by epigenetic drugs reduces post-ischemic brain injury in mice with an extended therapeutic window.
    Lanzillotta A; Pignataro G; Branca C; Cuomo O; Sarnico I; Benarese M; Annunziato L; Spano P; Pizzi M
    Neurobiol Dis; 2013 Jan; 49():177-89. PubMed ID: 22971966
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Arctigenin derivative A-1 ameliorates motor dysfunction and pathological manifestations in SOD1
    Xiong B; Yang C; Yang X; Luo S; Li S; Chen C; He K; Nie L; Li P; Li S; Huang H; Liu J; Zhang Z; Xie Y; Zou L; Yang X
    CNS Neurosci Ther; 2024 Jun; 30(6):e14692. PubMed ID: 38872258
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sodium valproate increases activity of the sirtuin pathway resulting in beneficial effects for spinocerebellar ataxia-3 in vivo.
    Watchon M; Luu L; Robinson KJ; Yuan KC; De Luca A; Suddull HJ; Tym MC; Guillemin GJ; Cole NJ; Nicholson GA; Chung RS; Lee A; Laird AS
    Mol Brain; 2021 Aug; 14(1):128. PubMed ID: 34416891
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduced sirtuin 1/adenosine monophosphate-activated protein kinase in amyotrophic lateral sclerosis patient-derived mesenchymal stem cells can be restored by resveratrol.
    Yun YC; Jeong SG; Kim SH; Cho GW
    J Tissue Eng Regen Med; 2019 Jan; 13(1):110-115. PubMed ID: 30479062
    [TBL] [Abstract][Full Text] [Related]  

  • 9. "Preconditioning" with latrepirdine, an adenosine 5'-monophosphate-activated protein kinase activator, delays amyotrophic lateral sclerosis progression in SOD1(G93A) mice.
    Coughlan KS; Mitchem MR; Hogg MC; Prehn JH
    Neurobiol Aging; 2015 Feb; 36(2):1140-50. PubMed ID: 25443289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Restoration of histone acetylation ameliorates disease and metabolic abnormalities in a FUS mouse model.
    Rossaert E; Pollari E; Jaspers T; Van Helleputte L; Jarpe M; Van Damme P; De Bock K; Moisse M; Van Den Bosch L
    Acta Neuropathol Commun; 2019 Jul; 7(1):107. PubMed ID: 31277703
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurorestoration induced by the HDAC inhibitor sodium valproate in the lactacystin model of Parkinson's is associated with histone acetylation and up-regulation of neurotrophic factors.
    Harrison IF; Crum WR; Vernon AC; Dexter DT
    Br J Pharmacol; 2015 Aug; 172(16):4200-15. PubMed ID: 26040297
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined lithium and valproate treatment delays disease onset, reduces neurological deficits and prolongs survival in an amyotrophic lateral sclerosis mouse model.
    Feng HL; Leng Y; Ma CH; Zhang J; Ren M; Chuang DM
    Neuroscience; 2008 Aug; 155(3):567-72. PubMed ID: 18640245
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Guanabenz delays the onset of disease symptoms, extends lifespan, improves motor performance and attenuates motor neuron loss in the SOD1 G93A mouse model of amyotrophic lateral sclerosis.
    Jiang HQ; Ren M; Jiang HZ; Wang J; Zhang J; Yin X; Wang SY; Qi Y; Wang XD; Feng HL
    Neuroscience; 2014 Sep; 277():132-8. PubMed ID: 24699224
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Resveratrol ameliorates motor neuron degeneration and improves survival in SOD1(G93A) mouse model of amyotrophic lateral sclerosis.
    Song L; Chen L; Zhang X; Li J; Le W
    Biomed Res Int; 2014; 2014():483501. PubMed ID: 25057490
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lack of synergistic effect of resveratrol and sigma-1 receptor agonist (PRE-084) in SOD1G⁹³A ALS mice: overlapping effects or limited therapeutic opportunity?
    Mancuso R; Del Valle J; Morell M; Pallás M; Osta R; Navarro X
    Orphanet J Rare Dis; 2014 May; 9():78. PubMed ID: 24885036
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fasudil, a rho kinase inhibitor, limits motor neuron loss in experimental models of amyotrophic lateral sclerosis.
    Takata M; Tanaka H; Kimura M; Nagahara Y; Tanaka K; Kawasaki K; Seto M; Tsuruma K; Shimazawa M; Hara H
    Br J Pharmacol; 2013 Sep; 170(2):341-51. PubMed ID: 23763343
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuroprotective effects of the Sigma-1 receptor (S1R) agonist PRE-084, in a mouse model of motor neuron disease not linked to SOD1 mutation.
    Peviani M; Salvaneschi E; Bontempi L; Petese A; Manzo A; Rossi D; Salmona M; Collina S; Bigini P; Curti D
    Neurobiol Dis; 2014 Feb; 62():218-32. PubMed ID: 24141020
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of Class II-Selective Histone Deacetylase Inhibitor on Neuromuscular Function and Disease Progression in SOD1-ALS Mice.
    Buonvicino D; Felici R; Ranieri G; Caramelli R; Lapucci A; Cavone L; Muzzi M; Di Pietro L; Bernardini C; Zwergel C; Valente S; Mai A; Chiarugi A
    Neuroscience; 2018 May; 379():228-238. PubMed ID: 29588251
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuroprotective effects of JGK-263 in transgenic SOD1-G93A mice of amyotrophic lateral sclerosis.
    Ahn SW; Jeon GS; Kim MJ; Shon JH; Kim JE; Shin JY; Kim SM; Kim SH; Ye IH; Lee KW; Hong YH; Sung JJ
    J Neurol Sci; 2014 May; 340(1-2):112-6. PubMed ID: 24680562
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tissue-specific deregulation of selected HDACs characterizes ALS progression in mouse models: pharmacological characterization of SIRT1 and SIRT2 pathways.
    Valle C; Salvatori I; Gerbino V; Rossi S; Palamiuc L; René F; Carrì MT
    Cell Death Dis; 2014 Jun; 5(6):e1296. PubMed ID: 24946089
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.